| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
3,541 |
3,258 |
$808K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
7,291 |
6,995 |
$480K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
3,038 |
2,736 |
$76K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,265 |
1,248 |
$69K |
| 71046 |
Radiologic examination, chest; 2 views |
863 |
789 |
$57K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,896 |
2,788 |
$45K |
| 87430 |
|
3,186 |
3,083 |
$40K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
3,551 |
3,410 |
$32K |
| 87070 |
|
2,574 |
2,477 |
$31K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
264 |
260 |
$25K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
263 |
247 |
$21K |
| 80053 |
Comprehensive metabolic panel |
2,412 |
1,981 |
$15K |
| 71045 |
Radiologic examination, chest; single view |
705 |
636 |
$14K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
405 |
384 |
$13K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
143 |
135 |
$12K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
2,639 |
2,248 |
$12K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
106 |
83 |
$8K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
48 |
47 |
$8K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
264 |
241 |
$7K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
370 |
308 |
$6K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
240 |
239 |
$6K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
639 |
522 |
$4K |
| 81001 |
|
1,232 |
1,100 |
$3K |
| 87807 |
|
242 |
233 |
$3K |
| 81003 |
|
917 |
852 |
$3K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
47 |
45 |
$2K |
| 70450 |
Computed tomography, head or brain; without contrast material |
32 |
26 |
$2K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
229 |
213 |
$1K |
| 83880 |
|
144 |
124 |
$1K |
| 84484 |
|
376 |
260 |
$1K |
| 81025 |
|
143 |
128 |
$807.20 |
| 96361 |
Intravenous infusion, hydration; each additional hour |
147 |
105 |
$557.46 |
| 86140 |
|
173 |
154 |
$446.58 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
139 |
113 |
$292.20 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
339 |
260 |
$191.58 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
28 |
27 |
$156.51 |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
339 |
293 |
$152.54 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
286 |
249 |
$141.24 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
12 |
12 |
$124.07 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
165 |
143 |
$116.30 |
| 83735 |
|
76 |
60 |
$108.12 |
| 84443 |
Thyroid stimulating hormone (TSH) |
13 |
13 |
$82.53 |
| 83690 |
|
28 |
27 |
$68.03 |
| 0031A |
|
29 |
29 |
$59.98 |
| 82150 |
|
13 |
13 |
$48.15 |
| 36415 |
Collection of venous blood by venipuncture |
46 |
44 |
$39.18 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
40 |
39 |
$34.00 |
| 87077 |
|
14 |
13 |
$26.14 |
| 80061 |
Lipid panel |
44 |
39 |
$21.38 |
| 0012A |
|
18 |
17 |
$5.94 |
| A9270 |
Non-covered item or service |
98 |
77 |
$0.00 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
13 |
13 |
$0.00 |